India Exchange Filings

Titan Biotech Q2 FY27 Results Approved

Titan Biotech Ltd approves Q2 FY27 results, with standalone net profit up 65.1% year on year to ₹1,133.07 lakh

  • Q2 standalone revenue rose 31.0% year on year to ₹7,646.25 lakh; estimated operating margin was 17.9%.
  • Consolidated net profit was ₹1,254.78 lakh, including ₹121.66 lakh share of profit from associates.
  • No exceptional items were reported; auditors’ limited-review conclusions were unmodified.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.